TY  - JOUR
AU  - Zaganjor, Ibrahim
AU  - Saelee, Ryan
AU  - Onufrak, Stephen
AU  - Miyamoto, Yoshihisa
AU  - Koyama, Alain K.
AU  - Xu, Fang
AU  - Bullard, Kai McKeever
AU  - Pavkov, Meda E.
PY  - 2024
TI  - Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022
T2  - Preventing Chronic Disease
JO  - Prev Chronic Dis
SP  - E90
VL  - 21
CY  - Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
N2  - We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.
SN  - 1545-1151
UR  - https://doi.org/10.5888/pcd21.240229
DO  - 10.5888/pcd21.240229
ER  -